Intuitive Surgical reported first quarter 2026 revenue of $2.77 billion and non-GAAP EPS of $2.50, exceeding analyst expectations. The results were driven by strong growth in system placements and a significant increase in da Vinci procedure volume.

Key Highlights

  • Worldwide da Vinci procedures grew 16% year-over-year, coming in ahead of the 14% consensus estimate and at the high end of the company's updated full-year 2026 guidance range of 13.5% to 15.5%.
  • The company placed 431 da Vinci surgical systems, a 17% increase from the prior year, with the new da Vinci 5 platform accounting for 232 of the systems placed.
  • Instruments and accessories revenue, a key recurring metric tied to procedures, increased 23% year-over-year to $1.69 billion.